The Resonator™ Device Compared to
Other Parkinson's Disease Therapies


Surgical Options and Devices:

Only 15-20% of PD patients are candidates for surgical options.
The options include:

Ablative Surgery
Invasive: Involves destroying a small target within the brain that generates symptoms of Parkinson's disease by inserting a heated probe or electrode resulting in focal tissue destruction.

Serious Adverse Effects:
Include intracerebral hemorrhage, infection and inadequate or lack of benefit.


Deep Brain Stimulation (DBS)

Invasive: Specific sections  of the brain are chronically stimulated by a permanently implanted electrode(s) connected via a wire running beneath the skin to a stimulator and battery pack in the patient's chest.

Serious Adverse Effects:  Include intracerebral hemorrhage, hardware breakage or malfunction,  infection.

Postoperatively: Extensive follow-up visits required of patient to program the stimulator. Also, the battery must replaced periodically.


Drug Therapies:

Systemic: Given the chronic nature of the disease, increasing dosage of drugs over time increases the chance for serious adverse effects described below.

Serious Adverse Effects : Include risk of depression, hypotension, abnormal movements of the face and limbs, bowel and liver dysfunction, hallucinations and also nausea, dizziness, constipation, blurred vision and dry mouth.


The Resonator™ Device

  • Non-Invasive
  • Non-Significant risk
  • Non-Systemic
  • Serious Adverse Effects: None reported
  • Is used as an Adjunctive Therapy (ie in addition to patient’s current treatment or “standard of care.”)

 

 

Please Download the latest version of Adobe Flash Player.

 

ABOUT US

Our Team

Participate in our research
News Releases

Terms & Conditions of Use

 
 
   
   
 
 

4700 140th Ave. N., Suite 101 • Clearwater, FL 33762 • 727-474-3722

HOME | CONTACT US

 
 

The Resonator™ device is an Investigational Device limited by Federal (or United States)
law to investigational use. The Resonator™ device is not for sale, nor is the Magneceutical®
Therapy generally available outside of Investigational Review Board (IRB) approved clinical studies.